ATE492640T1 - Loslösendes protein 5 - ucp5 - Google Patents
Loslösendes protein 5 - ucp5Info
- Publication number
- ATE492640T1 ATE492640T1 AT99973036T AT99973036T ATE492640T1 AT E492640 T1 ATE492640 T1 AT E492640T1 AT 99973036 T AT99973036 T AT 99973036T AT 99973036 T AT99973036 T AT 99973036T AT E492640 T1 ATE492640 T1 AT E492640T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- present
- ucp5
- nucleic acid
- releasing protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11028698P | 1998-11-30 | 1998-11-30 | |
US12958399P | 1999-04-16 | 1999-04-16 | |
US14388699P | 1999-07-15 | 1999-07-15 | |
PCT/US1999/025947 WO2000032624A2 (en) | 1998-11-30 | 1999-11-03 | Uncoupling protein 5 - ucp5 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE492640T1 true ATE492640T1 (de) | 2011-01-15 |
Family
ID=27380826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99973036T ATE492640T1 (de) | 1998-11-30 | 1999-11-03 | Loslösendes protein 5 - ucp5 |
Country Status (8)
Country | Link |
---|---|
US (2) | US6967245B2 (de) |
EP (1) | EP1135496B1 (de) |
JP (1) | JP2002533062A (de) |
AT (1) | ATE492640T1 (de) |
AU (1) | AU774760B2 (de) |
CA (1) | CA2349839C (de) |
DE (1) | DE69943058D1 (de) |
WO (1) | WO2000032624A2 (de) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4775662A (en) * | 1983-03-07 | 1988-10-04 | Smithkline Beckman Corporation | Leukotriene antagonists |
US5010003A (en) * | 1983-04-25 | 1991-04-23 | Genentech, Inc. | Use of yeast homologous signals to secrete heterologous proteins |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
US5407810A (en) * | 1993-08-20 | 1995-04-18 | Genentech, Inc. | Aqueous multiple-phase isolation of polypeptide |
US5861485A (en) * | 1994-08-23 | 1999-01-19 | Millennium Pharmaceuticals, Inc. | Polypeptides involved in body weight disorders, including obesity |
US6534631B1 (en) * | 1998-07-15 | 2003-03-18 | Human Genome Sciences, Inc. | Secreted protein HT5GJ57 |
WO1998045438A1 (en) * | 1997-04-09 | 1998-10-15 | Beth Israel Deaconess Medical Center | Ucp3: an uncoupling protein homologue |
WO1998052958A1 (en) | 1997-05-20 | 1998-11-26 | Merck & Co., Inc. | Human uncoupling protein 3 |
WO2000004037A1 (en) * | 1998-07-14 | 2000-01-27 | Amylin Pharmaceuticals, Inc. | Uncoupling protein 4 (ucp-4) and methods of use |
-
1999
- 1999-11-03 EP EP99973036A patent/EP1135496B1/de not_active Expired - Lifetime
- 1999-11-03 AU AU14667/00A patent/AU774760B2/en not_active Expired
- 1999-11-03 WO PCT/US1999/025947 patent/WO2000032624A2/en active IP Right Grant
- 1999-11-03 AT AT99973036T patent/ATE492640T1/de not_active IP Right Cessation
- 1999-11-03 DE DE69943058T patent/DE69943058D1/de not_active Expired - Lifetime
- 1999-11-03 JP JP2000585265A patent/JP2002533062A/ja active Pending
- 1999-11-03 CA CA2349839A patent/CA2349839C/en not_active Expired - Lifetime
-
2002
- 2002-10-15 US US10/270,861 patent/US6967245B2/en not_active Expired - Lifetime
-
2008
- 2008-02-04 US US12/012,569 patent/US20080312417A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69943058D1 (de) | 2011-02-03 |
US20080312417A1 (en) | 2008-12-18 |
WO2000032624A2 (en) | 2000-06-08 |
WO2000032624A3 (en) | 2000-11-09 |
AU774760B2 (en) | 2004-07-08 |
EP1135496A2 (de) | 2001-09-26 |
CA2349839C (en) | 2013-10-08 |
JP2002533062A (ja) | 2002-10-08 |
AU1466700A (en) | 2000-06-19 |
US20030077749A1 (en) | 2003-04-24 |
US6967245B2 (en) | 2005-11-22 |
CA2349839A1 (en) | 2000-06-08 |
EP1135496B1 (de) | 2010-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE447583T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
WO1999055868A3 (en) | Fizz proteins | |
MXPA01002592A (es) | Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos. | |
KR100468977B1 (ko) | 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 | |
DE60137829D1 (de) | Menschliche stra6 polypeptide | |
WO2000039297A3 (en) | Il-1 related polypeptides | |
ATE492640T1 (de) | Loslösendes protein 5 - ucp5 | |
EP1241179A3 (de) | Menschliches Cornichon-ähliches Protein und dafür kodierende Nukleinsäure | |
ATE415422T1 (de) | Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren | |
EP1251139A3 (de) | Menschliches mindin-ähliches Protein und dafür kodierende Nukleinsäure | |
PT1241251E (pt) | Proteína semelhante a prostasina humana e ácidos nucleicos que a codificam | |
ATE402954T1 (de) | Menschliches a33-antigen-ähnliches protein und dafür kodierende nukleinsäure | |
ATE405590T1 (de) | Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure | |
ATE404585T1 (de) | Menschliches synaptogyrin-ähnliches protein und dafür kodierende nukleinsäure | |
EP2050762A3 (de) | Neue Polypeptide und für diese kodierende Nukleinsäuren | |
EP1241252A3 (de) | Menschliches Enteropeptidase-ähnliches Protein und dafür kodierende Nukleinsäure | |
EP1247817A3 (de) | Menschliches CD-23-ähliches Protein und dafür kodierende Nukleinsäure | |
DE60043258D1 (de) | Menschliches suppressor von fused | |
EP1241185A3 (de) | Menschliches Protocadherin-ähnliches Protein und dafür kodierende Nukleinsäure | |
DE69827532D1 (de) | Polypeptide und dafür kodierende Nukleinsäure | |
DE69829417D1 (de) | Polypeptide und dafür kodierende Nukleinsäure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |